Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: a multicenter retrospective study.

Supplemental Table 1. Baseline characteristics of 42 patients with follicular reactions related to ICIs.
Supplemental Table 2. Clinical differences between acneiform rash, papulopustular rosacea, folliculitis, and hidradenitis suppurativa attributed to immune checkpoint inhibitors and differential diagnosis to consider in cancer patients
Supplemental Table 3. Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0). Following the clinical features and distribution described for each case of follicular cirAE, the severity grading was obtained by oncodermatologists from the clinical description if not available by the grading CTCAEv5.0.